X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (724) 724
Patent (98) 98
Publication (97) 97
Conference Proceeding (18) 18
Book Chapter (11) 11
Newspaper Article (3) 3
Reference (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (281) 281
humans (245) 245
male (204) 204
female (201) 201
middle aged (156) 156
aged (122) 122
adult (112) 112
animals (103) 103
risk factors (86) 86
research (82) 82
electricity (76) 76
conversion or distribution of electric power (74) 74
dynamo-electric machines (74) 74
generation (74) 74
analysis (71) 71
general tagging of cross-sectional technologies spanning over several sections of the ipc (61) 61
general tagging of new technological developments (61) 61
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (61) 61
mortality (58) 58
health aspects (55) 55
norway (54) 54
cardiovascular disease (52) 52
condensed matter - mesoscale and nanoscale physics (51) 51
studies (47) 47
technical subjects covered by former uspc (47) 47
technical subjects covered by former us classification (46) 46
epidemiology (45) 45
research article (45) 45
risk (45) 45
norway - epidemiology (43) 43
condensed matter (42) 42
medicine (42) 42
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (42) 42
technologies or applications for mitigation or adaptation againstclimate change (42) 42
physics, applied (39) 39
mesoscopic systems and quantum hall effect (36) 36
homocysteine (35) 35
nutrition & dietetics (35) 35
prognosis (35) 35
prospective studies (35) 35
public, environmental & occupational health (35) 35
aged, 80 and over (34) 34
gene expression (34) 34
materials science, multidisciplinary (34) 34
medical research (34) 34
nanowires (34) 34
physiological aspects (34) 34
care and treatment (32) 32
follow-up studies (32) 32
metabolism (31) 31
plasma (31) 31
proteins (31) 31
biomarkers (30) 30
cardiovascular diseases (30) 30
young adult (30) 30
adolescent (29) 29
cohort studies (29) 29
multidisciplinary sciences (29) 29
patients (28) 28
surveys and questionnaires (28) 28
biology (27) 27
time factors (27) 27
cholesterol (26) 26
health risk assessment (26) 26
homocysteine - blood (26) 26
physics, multidisciplinary (26) 26
cardiac & cardiovascular systems (25) 25
condensed matter - superconductivity (25) 25
diagnosis (25) 25
inflammation (25) 25
medicin och hälsovetenskap (25) 25
physics (25) 25
age (24) 24
ecology (24) 24
genetic aspects (24) 24
heart diseases (24) 24
biomarkers - blood (23) 23
cancer (23) 23
case-control studies (23) 23
disease (23) 23
infectious diseases (23) 23
medical and health sciences (23) 23
mice (23) 23
nanoscience & nanotechnology (23) 23
physics, condensed matter (23) 23
regression analysis (23) 23
diet (22) 22
expression (22) 22
incidence (22) 22
angina pectoris (21) 21
body mass index (21) 21
cardiovascular-disease (21) 21
coronary heart disease (21) 21
health (21) 21
medicine, general & internal (21) 21
oncology (21) 21
rats (21) 21
risk assessment (21) 21
science (21) 21
superconductivity (21) 21
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (820) 820
French (31) 31
German (24) 24
Spanish (14) 14
Norwegian (8) 8
Czech (3) 3
Danish (3) 3
Korean (3) 3
Portuguese (3) 3
Chinese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Mendes-Ferreira, P and Maia-Rocha, C and Adao, R and Lourenco, A. P and Moura, C and Pinho, S and Areias, J. C and De Keulenaer, G. W and Leite-Moreira, A. F and Bras-Silva, C and Holzhauser, L and Lindner, D and Jenke, A and Schultheiss, H.- P and Westermann, D and Skurk, C and Misaka, T and Suzuki, S and Miyata, M and Kobayashi, A and Saitoh, S and Takeishi, Y and Czolbe, M and Pekarek, V and Williams, T and Panther, F and Strassen, J and Ritter, O and Voss, S and Nef, H. M and Szardien, S and Troidl, C and Kojonazarov, B and Visser, D and Hoffmann, J and Willmer, M and Hamm, C. W and Moellmann, H and Ljubojevic, S and Sedej, S and Sacherer, M and Leitinger, G and Kockskaemper, J and Pieske, B and Vorobyeva, N. M and Dobrovolsky, A. B and Titaeva, E. V and Kirienko, A. I and Panchenko, E. P and Nakamura, R and Matsue, Y and Mizukami, A and Ohno, M and Suzuki, M and Matsumura, A and Hashimoto, Y and Rosiak, M and Postula, M and Kaplon-Cieslicka, A and Trzepla, E and Czlonkowski, A and Filipiak, K. J and Opolski, G and Kosior, D. A and Andersson, T and Nagy, P and Niazi, M and Nylander, S and Wallentin, L and Mendell, J and Johnson, L and Ridout, G and He, L and Chen, S and Petrkova, M and Schneiderova, P and Kriegova, E and Kolar, Z and Taborsky, M and Petrek, M and Khuseyinova, N and Schnabel, R and Zeller, T and Gori, T and Schulz, A and Espinola-Klein, C and Lackner, K. J and Blankenberg, S and Muenzel, T. F and Wild, P. S and Amabile, N and Cheng, S and Larson, M. G and Ghorbani, A and Mc Cabe, E and Griffin, G and Cohen, K. S and Tedgui, A and Boulanger, C. M and Wang, T. J and ... and on behalf of BBC ONE investigators and on behalf of WHICH? Trial Investigators and on behalf of EPES Acute Cardiac Care group and on behalf of Interventional Genetic Study Group in Cardiovascular Disease's and on behalf of HPS2-THRIVE Collaborative Group and on behalf of Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) and on behalf of The Milan and New-Tokyo Registry and on behalf of SAFETY Investigators and on behalf of Advance CRT Investigators and on behalf of the ARVA Investigators and on behalf of TIMI Study Group and on behalf of REFINE ICD Investigators and on behalf of RO-AHFS Study Investigators and on behalf of The PASCAL Investigators and on behalf of the KorHF investigators and on behalf of TECAM and on behalf of The INSIGHT (R)XT investigators and on behalf of ATA-AF investigators and on behalf of The ODIN Participants and on behalf of CREDO-Kyoto Registry Cohort-2 Investigators and on behalf of AHEAD investigators and on behalf of the RESET investigators and on behalf of ABSORB Cohort B and on behalf of RE-LY Trial Investigators and on behalf of the CORONA Study Group and on behalf of PROTECTOME and on behalf of CoLaus Study and on behalf of OFRECE Study and on behalf of BBK Registry and on behalf of FAST-MI 2010 and on behalf of ATOLL investigators and on behalf of HARVEST study group and on behalf of Royal Brompton Hospital NIHR Cardiovascular Biomedical Research Unit and on behalf of the PROSPER study group and on behalf of MAGGIC study group and on behalf of the DANPACE Investigators and on behalf of German Conn's Registry and on behalf of NANOPLASTY group and on behalf of j-Cypher Registry and on behalf of NIL-CHF Study Investigators and on behalf of the FAST-MI 2010 investigators and on behalf of Competence Network Heart Failure and on behalf of Gothia Cardiovascular and on behalf of OPTIMISE CRT Investigators and on behalf of EVEREST trial investigators and on behalf of The Tohoku Acute Heart Failure Registry and on behalf of investigators of the national registry of ACS, Portuguese Society of Cardiology and on behalf of BIOSOLVE-I Investigators and on behalf of Department of Cardiology, Second Hospital of Tianjin Medical University and on behalf of THALES Registry Investigators and on behalf of STICH Investigators and on behalf of Young @ Heart Investigators and on behalf of PROCARDIS Consortium and on behalf of PEGASO and on behalf of The SWEDEHEART group and on behalf of BWGIC (Belgian Working Group of Invasive Cardiology and on behalf of Med in NRW and For The Topp Registry Investigators and on behalf of PRISON and on behalf of ARISTOTLE investigators and on behalf of the RACE II investigators and on behalf of Euro Heart Survey PCI registry investigators and on behalf of the SPICE investigators and on behalf of The ISAR REACT 4 Investigators and on behalf of Yokohama Medical Center Clinical Research group and on behalf of DiaRegis-Study-Group and on behalf of The RHYTHM-AF Study Scientific Committee and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of AMIS Plus Investigators and on behalf of SYNTAX Investigators and on behalf of Advantage Predictors of Acute Coronary Syndrome Evaluation and on behalf of CREATE investigator group and on behalf of Follow Your Heart Project and on behalf of SYNTAX Trial Investigators and on behalf of WELCOME Study Investigators and on behalf of Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) investigators and on behalf of investigators of the national registry of ACS, Portugese Society of Cardiology and on behalf of EVITA-HF (Evidence Based Treatment - Heart Failure) and on behalf of ESTROFA and on behalf of Second Department of Internal Medicine and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of PRAGUE-2 and on behalf of German Diabetes and Dialysis Study Investigators and on behalf of Hull LifeLab and on behalf of on behalf of the DYDA Investigators and on behalf of OFICA study group and on behalf of BASKET-PROVE and on behalf of the Triple-Site versus Standard Resynchronization Therapy Study (TRUST CRT) Investigators and on behalf of Scripps Translational Science Institute and on behalf of OMEGA study group and on behalf of PL-ACS Invastigators and on behalf of German Aortic Valve Therapy Registry and on behalf of TO BELIEVERS and on behalf of PREDICTION Study Group and on behalf of The REACH registry investigators and on behalf of PL-ACS Investigators and on behalf of KNHI and on behalf of Emerging Concepts in Cardiovascular Medicine and on behalf of CHART-2 Investigators and on behalf of the Fushimi AF Registry investigators and on behalf of Brasilian Heart Study Group and on behalf of Taiwan acute coronary syndrome full spetrum registry study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 339 - 653
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2019, Volume 73, Issue 4, pp. 387 - 396
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2019, Volume 74, Issue 9, pp. 1167 - 1176
Journal Article
Circulation, ISSN 0009-7322, 07/2019, Volume 140, Issue 2, pp. 103 - 112
Journal Article
by Ray, Kausik K and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Diaz, Rafael and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Loizeau, Virginie and Lopes, Renato D and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and Zeiher, Andreas M and Schwartz, Gregory G and Steg, Philippe Gabriel and Schwartz, Gregory G and Steg, Ph. Gabriel and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Goodman, Shaun G and Harrington, Robert A and Jukema, J. Wouter and Szarek, Michael and White, Harvey D and Zeiher, Andreas M and Tricoci, Pierluigi and Roe, Matthew T and Mahaffey, Kenneth W and Edelberg, Jay M and Hanotin, Corinne and Lecorps, Guillaume and Moryusef, Angèle and Pordy, Robert and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Lopes, Renato D and Gotcheva, Nina N and Prieto, Juan-Carlos and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Takeshi and Kim, Hyo Soo and Kim, Sang-Hyun and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Budaj, Andrzej and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Ristic, Arsen D and Chua, Terrance and Murin, Jan and Fras, Zlatko and Dalby, Anthony J and Tuñón, José and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Ray, Kausik K and Moriarty, Patrick M and Vogel, Robert and ... and ODYSSEY OUTCOMES Committees and Investigators and ODYSSEY OUTCOMES Comm Investigato and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article